Previsioni di mercato delle organizzazioni di vendita a contratto farmaceutiche per Medio Oriente e Africa fino al 2030 - Analisi regionale - per servizi (servizi commerciali e servizi non commerciali), moduli (moduli sindacati e moduli dedicati), area terapeutica (disturbi cardiovascolari, oncologia, disturbi metabolici, neurologia, Malattie ortopediche, malattie infettive e altre) e utente finale (aziende biofarmaceutiche e aziende farmaceutiche)
Espansione in I mercati emergenti alimentano il mercato delle organizzazioni di vendita a contratto farmaceutiche in Medio Oriente e Africa
La traiettoria futura del mercato delle organizzazioni di vendita a contratto farmaceutiche (CSO) è chiaramente modellata dalla tendenza strategica di espansione nei mercati emergenti. Mentre il panorama farmaceutico globale aumenta, le economie emergenti acquisiscono importanza e le organizzazioni della società civile riconoscono sempre più il potenziale non sfruttato. I mercati emergenti presentano opportunità guidate dalla crescente consapevolezza sanitaria, dall’espansione della popolazione della classe media e dall’aumento degli investimenti pubblici nelle infrastrutture sanitarie. Estendendo le loro operazioni in questi mercati in espansione, le organizzazioni della società civile possono trarre vantaggio dalla crescente domanda di prodotti farmaceutici e stabilire presto un forte punto d’appoggio nei mercati pronti per una crescita sostanziale. Tuttavia, questa espansione richiede una saggia comprensione del panorama normativo locale, delle sfumature culturali e dei diversi sistemi sanitari. Un\'espansione di successo nei mercati emergenti richiede un approccio su misura, in cui le organizzazioni della società civile devono allineare le proprie strategie alle sfide e alle opportunità uniche di ciascuna regione. Inoltre, tali espansioni posizionano le organizzazioni della società civile come attori cruciali nell’ecosistema sanitario globale, contribuendo alla crescita dei ricavi e all’obiettivo più ampio di migliorare l’accessibilità e i risultati dell’assistenza sanitaria in questi mercati in evoluzione. In sostanza, il movimento strategico verso l’espansione nei mercati emergenti emerge come una tendenza lungimirante, che riflette l’adattabilità e la lungimiranza delle organizzazioni della società civile farmaceutiche nell’affrontare le complessità di un panorama farmaceutico globalizzato.
Panoramica del mercato delle organizzazioni di vendita a contratto per prodotti farmaceutici in Medio Oriente e Africa
Il mercato delle organizzazioni di vendita a contratto per prodotti farmaceutici in Medio Oriente e Africa è segmentato in Arabia Saudita, Sud Africa, Emirati Arabi Uniti e resto del MEA. I fattori che guidano la crescita del mercato includono la crescente integrazione delle tecnologie digitali e il crescente interesse delle aziende farmaceutiche ad aumentare le vendite dei prodotti. Tuttavia, i problemi di qualità associati all’outsourcing ostacolano la crescita del mercato. Gli Emirati Arabi Uniti sono un paese sviluppato nella regione e il loro settore sanitario ha mostrato una crescita notevole, principalmente a causa dell\'aumento della popolazione e dell\'aumento della domanda di prodotti farmaceutici. Il settore sanitario progressista offre opportunità di crescita vitali all’industria farmaceutica. Gli Emirati Arabi Uniti hanno una delle industrie farmaceutiche in più rapida crescita al mondo, nota anche per l’adozione di tecnologie avanzate. Iniziative come la Strategia industriale di Dubai 2030 e la Visione di Abu Dhabi 2030 si concentrano sullo sviluppo del settore farmaceutico nazionale considerando le prospettive di crescita futura, il potenziale di esportazione e l\'impatto economico a medio e lungo termine. Progressi significativi nella ricerca scientifica favoriscono lo sviluppo e la produzione di potenziali farmaci innovativi. La forte concorrenza nel settore farmaceutico costringe le aziende a immettere i propri farmaci sul mercato il prima possibile per rimanere ai vertici del mercato. Pertanto, la crescente domanda di prodotti farmaceutici efficienti, un numero crescente di aziende farmaceutiche, l’aumento dell’incidenza di malattie infettive e croniche e i frequenti lanci di prodotti supportano il progresso dell’industria farmaceutica in Medio Oriente e Africa, rendendo quindi necessario l’uso di servizi CSO, che favorisce la crescita del mercato delle organizzazioni di vendita farmaceutica a contratto nella regione.
Previsioni e entrate del mercato delle organizzazioni di vendita a contratto farmaceutiche in Medio Oriente e Africa fino al 2030 (milioni di dollari)
Segmentazione del mercato delle organizzazioni di vendita a contratto farmaceutiche in Medio Oriente e Africa
Il mercato delle organizzazioni di vendita a contratto farmaceutiche in Medio Oriente e Africa è segmentato in servizi, moduli, area terapeutica, utente finale e paese.
Sulla base dei servizi, il mercato delle organizzazioni di vendita farmaceutica a contratto in Medio Oriente e Africa è suddiviso in servizi commerciali e servizi non commerciali. Nel 2022, il segmento dei servizi commerciali ha detenuto una quota maggiore del mercato delle organizzazioni di vendita a contratto di prodotti farmaceutici in Medio Oriente e Africa.
Sulla base dei moduli, il mercato delle organizzazioni di vendita a contratto di prodotti farmaceutici in Medio Oriente e Africa è suddiviso in moduli sindacati e moduli dedicati. Nel 2022, il segmento dei moduli sindacati deteneva una quota maggiore del mercato delle organizzazioni di vendita a contratto farmaceutiche in Medio Oriente e Africa.
In base all\'area terapeutica, il mercato delle organizzazioni di vendita a contratto farmaceutiche in Medio Oriente e Africa è segmentato in disturbi cardiovascolari, oncologia, disturbi metabolici , neurologia, malattie ortopediche, malattie infettive e altri. Il segmento oncologico ha detenuto la quota maggiore del mercato delle organizzazioni di vendita a contratto farmaceutiche in Medio Oriente e Africa nel 2022.
In base all\'utente finale, il mercato delle organizzazioni di vendita a contratto farmaceutiche in Medio Oriente e Africa è suddiviso in società biofarmaceutiche e aziende farmaceutiche. Nel 2022, il segmento delle aziende farmaceutiche deteneva una quota maggiore del mercato delle organizzazioni di vendita a contratto di prodotti farmaceutici in Medio Oriente e Africa.
In base al paese, il mercato delle organizzazioni di vendita a contratto di prodotti farmaceutici in Medio Oriente e Africa è segmentato in Arabia Saudita, Sud Africa, Emirati Arabi Uniti e il resto del Medio Oriente e dell\'Africa. L\'Arabia Saudita ha dominato il mercato delle organizzazioni di vendita farmaceutica a contratto in Medio Oriente e Africa nel 2022.
Aenova Holding GmbH, IQVIA Holdings Inc, Pfizer Inc e Syneos Health Inc sono alcune delle aziende leader che operano nelle vendite a contratto farmaceutiche in Medio Oriente e Africa mercato delle organizzazioni.
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East & Africa PEST Analysis
5. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Integration of Digital Technologies
5.1.2 Growing Interest of Pharmaceutical Companies to Increase Sales of Products
5.2 Key Market Restraints
5.2.1 Quality Issues Associated with Outsourcing
5.3 Key Market Opportunities
5.3.1 Rising Use of Telemedicine and Remote Detailing
5.4 Key Future Trends
5.4.1 Expansion in Emerging Markets
5.5 Impact Analysis:
6. Pharmaceutical Contract Sales Organizations Market - Middle East & Africa Analysis
6.1 Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030
7. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Services
7.1 Overview
7.2 Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
7.3 Commercial Services
7.3.1 Overview
7.3.2 Commercial Services: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Non-Commercial Services
7.4.1 Overview
7.4.2 Non-Commercial Services: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Modules
8.1 Overview
8.2 Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
8.3 Syndicated Modules
8.3.1 Overview
8.3.2 Syndicated Modules: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Dedicated Modules
8.4.1 Overview
8.4.2 Dedicated Modules: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Therapeutic Area
9.1 Overview
9.2 Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
9.3 Cardiovascular Disorders
9.3.1 Overview
9.3.2 Cardiovascular Disorders: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Oncology
9.4.1 Overview
9.4.2 Oncology: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Metabolic Disorders
9.5.1 Overview
9.5.2 Metabolic Disorders: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Neurology
9.6.1 Overview
9.6.2 Neurology: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.7 Orthopaedic Diseases
9.7.1 Overview
9.7.2 Orthopedic Diseases: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.8 Infectious Diseases
9.8.1 Overview
9.8.2 Infectious Diseases: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.9 Others
9.9.1 Overview
9.9.2 Others: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by End User
10.1 Overview
10.2 Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
10.3 Biopharmaceutical Companies
10.3.1 Overview
10.3.2 Biopharmaceutical Companies: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Pharmaceutical Companies
10.4.1 Overview
10.4.2 Pharmaceutical Companies: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
11. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Country Analysis
11.1 Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Country
11.1.1 Saudi Arabia
11.1.1.1 Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.2 Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.1.3 Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.1.4 Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.1.5 Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.2 UAE
11.1.2.1 UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.2 UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.2.3 UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.2.4 UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.2.5 UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.3 South Africa
11.1.3.1 South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.3.2 South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.3.3 South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.3.4 South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.3.5 South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.4 Rest of Middle East & Africa
11.1.4.1 Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.4.2 Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.4.3 Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.4.4 Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.4.5 Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
12. Pharmaceutical Contract Sales Organizations Market - Industry Landscape
12.1 Overview
12.2 Growth Strategies
12.2.1 Overview
13. Company Profiles
13.1 IQVIA Holdings Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Syneos Health Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Aenova Holding GmbH
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Pfizer Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms
?
List of Tables
Table 1. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Segmentation
Table 2. Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 3. Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 4. Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 5. Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 6. UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 7. UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 8. UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 9. UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 10. South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 11. South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 12. South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 13. South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 14. Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 15. Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 16. Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 17. Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 18. Recent Growth Strategies in the Pharmaceutical Contract Sales Organizations Market
Table 19. Glossary of Terms, Middle East & Africa Pharmaceutical Contract Sales Organizations Market
?
List of Figures
Figure 1. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Segmentation, By Country
Figure 2. Middle East & Africa - PEST Analysis
Figure 3. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030
Figure 6. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
Figure 7. Commercial Services: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Non-Commercial Services: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
Figure 10. Syndicated Modules: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Dedicated Modules: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
Figure 13. Cardiovascular Disorders: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Oncology: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Metabolic Disorders: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Neurology: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Orthopedic Diseases: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Infectious Diseases: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 21. Biopharmaceutical Companies: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Pharmaceutical Companies: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Key Country - Revenue, 2022 (US$ Million)
Figure 24. Middle East & Africa Pharmaceutical Contract Sales Organizations Market, By Key Countries, 2022 and 2030 (%)
Figure 25. Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
1. Aenova Holding GmbH
2. IQVIA Holdings Inc
3. Pfizer Inc
4. Syneos Health Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa Pharmaceutical Contract Sales Organizations Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa Pharmaceutical Contract Sales Organizations Market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.